{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2021/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Brian Stephen Gerstenberger", "item": "https://www.patentleaderboard.com/2021/inventor/fl:br_ln:gerstenberger-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BG

Brian Stephen Gerstenberger — 3 Patents in 2021

Pfizer: 3 patents #17 of 325Top 6%
Cambridge, MA: #183 of 1,823 inventorsTop 15%
Massachusetts: #1,400 of 14,123 inventorsTop 10%
Overall (2021): #89,048 of 548,734Top 20%
3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11197867 Aminopyrimidinyl compounds Andrew Fensome, Ariamala Gopalsamy, Ivan Viktorovich Efremov, Zhao-Kui Wan, Betsy Susan Pierce +5 more 2021-12-14 $1,320,244,000
10980815 Aminopyrimidinyl compounds Andrew Fensome, Ariamala Gopalsamy, Ivan Viktorovich Efremov, Zhao-Kui Wan, Betsy Susan Pierce +5 more 2021-04-20 $674,734,000
10975065 N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors Andrew Christopher Flick, Vincent Michael Lombardo, James John Mousseau, Philippe Marcel Nuhant, Ralph P. Robinson +7 more 2021-04-13 $1,297,023,000